Goldman Sachs Group Inc Alx Oncology Holdings Inc Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 18,594 shares of ALXO stock, worth $23,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,594

Previous 289,693 93.58%

Holding current value

$23,800

Previous $121,000 71.9%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.44 - $1.87 $119,283 - $506,955	-271,099 Reduced 93.58%	18,594 $34,000
Q2 2025 Aug 14, 2025	SELL	$0.41 - $0.61 $34,243 - $50,947	-83,521 Reduced 22.38%	289,693 $121,000
Q1 2025 May 09, 2025	SELL	$0.62 - $1.86 $121,392 - $364,178	-195,795 Reduced 34.41%	373,214 $231,000
Q4 2024 Feb 11, 2025	BUY	$1.21 - $1.87 $377,677 - $583,683	312,130 Added 121.51%	569,009 $950,000
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $75,344 - $338,427	41,627 Added 19.34%	256,879 $467,000

Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $340,180 - $1.02 Million	58,250 Added 37.1%	215,252 $1.3 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.79 $725,536 - $1.11 Million	66,259 Added 73.02%	157,002 $1.75 Million
Q4 2023 Feb 13, 2024	SELL	$4.81 - $15.38 $194,247 - $621,105	-40,384 Reduced 30.8%	90,743 $1.35 Million
Q3 2023 May 14, 2024	BUY	$4.19 - $7.35 $169,208 - $296,822	40,384 Added 44.5%	131,127 $629,000
Q3 2023 Nov 14, 2023	SELL	$4.19 - $7.35 $203,801 - $357,504	-48,640 Reduced 27.06%	131,127 $629,000
Q2 2023 May 14, 2024	SELL	$4.37 - $9.56 $3,845 - $8,412	-880 Reduced 0.49%	179,767 $1.35 Million
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $3,845 - $8,412	-880 Reduced 0.49%	179,767 $1.35 Million
Q1 2023 May 14, 2024	BUY	$4.52 - $11.71 $23,440 - $60,728	5,186 Added 2.96%	180,647 $816,000
Q1 2023 May 11, 2023	BUY	$4.52 - $11.71 $23,440 - $60,728	5,186 Added 2.96%	180,647 $816,000
Q4 2022 May 14, 2024	BUY	$9.51 - $12.95 $139,939 - $190,559	14,715 Added 9.15%	175,461 $1.98 Million
Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $139,939 - $190,559	14,715 Added 9.15%	175,461 $1.98 Million
Q3 2022 May 14, 2024	SELL	$8.23 - $15.14 $715,985 - $1.32 Million	-86,997 Reduced 35.12%	160,746 $1.54 Million
Q3 2022 Nov 10, 2022	SELL	$8.23 - $15.14 $715,985 - $1.32 Million	-86,997 Reduced 35.12%	160,746 $1.54 Million
Q2 2022 May 14, 2024	BUY	$5.89 - $19.46 $924,730 - $3.06 Million	157,000 Added 173.02%	247,743 $2 Million
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $195,883 - $647,181	33,257 Added 15.51%	247,743 $2 Million
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $1.03 Million - $1.66 Million	75,348 Added 54.15%	214,486 $3.63 Million
Q4 2021 Feb 14, 2022	SELL	$21.49 - $74.4 $512,708 - $1.78 Million	-23,858 Reduced 14.64%	139,138 $2.99 Million
Q3 2021 Nov 10, 2021	BUY	$52.51 - $80.91 $8.56 Million - $13.2 Million	162,996 New	162,996 $12 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

30.3M

Call Options Held

173K

Put Options Held

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $52.2M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Alx Oncology Holdings Inc Transaction History